Induction of Transplant Tolerance in LDLT Via iTS

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT04950842

Recruitment Status : Active, not recruiting

First Posted : July 6, 2021

Last Update Posted : March 28, 2024

View this study on the modernized ClinicalTrials.gov

Sponsor:

Collaborator:

Junten Bio Co., Ltd.

Information provided by (Responsible Party):

Koichiro Uchida, Juntendo University

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Active, not recruiting
Estimated Primary Completion Date :	February 28, 2026
Estimated Study Completion Date :	February 28, 2026

Publications of Results:

Todo S, Yamashita K, Goto R, Zaitsu M, Nagatsu A, Oura T, Watanabe M, Aoyagi T, Suzuki T, Shimamura T, Kamiyama T, Sato N, Sugita J, Hatanaka K, Bashuda H, Habu S, Demetris AJ, Okumura K. A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation. Hepatology. 2016 Aug;64(2):632-43. doi: 10.1002/hep.28459. Epub 2016 Mar 10.

To Top